- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
TK2 Antibody (C-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AP14865b | 0.1 mg 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
| AP14865b-ev20 | 20 ug 100 ul | In Stock | $ 95.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
TK2 Antibody (C-term) - Product info | |
| Application | WB, IHC
|
| Primary Accession | O00142 |
| Other Accession | NP_001166114.1, NP_004605.4 |
| Reactivity | Human |
| Concentration | 0.25 mg/ml |
| Isotype | Rabbit Ig |
| Calculated MW | 31005 Da |
TK2 Antibody (C-term) - Additional info | |
| Gene ID 7084 | |
| Other Names TK2; Thymidine kinase 2, mitochondrial; Mt-TK | |
| Target/Specificity This TK2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 233-263 amino acids from the C-terminal region of human TK2. | |
| Dilution WB~~1:100~500WB~~1:1000 IHC~~1:10~50 | |
| Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions TK2 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures. | |
TK2 Antibody (C-term) - Protein Information | |
| Name TK2 | |
| Function Deoxyribonucleoside kinase that phosphorylates thymidine, deoxycytidine, and deoxyuridine. Also phosphorylates anti-viral and anti-cancer nucleoside analogs | |
| Cellular Location Mitochondrion. | |
| Tissue Location Predominantly expressed in liver, pancreas, muscle, and brain | |
TK2 Antibody (C-term) - Related products
AP14865b: TK2 Antibody (C-term)
AP7062a: Thymidine Kinase 2 Antibody (N-term)
AP7062b: Thymidine Kinase 2 Antibody (C-term)
TK2 Antibody (C-term) - Application data
-
TK2 Antibody (C-term) (Cat. #AP14865b) western blot analysis in A549 cell line lysates (35ug/lane).This demonstrates the TK2 antibody detected the TK2 protein (arrow).
-
TK2 Antibody (C-term) (AP14865b)immunohistochemistry analysis in formalin fixed and paraffin embedded human kidney tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of TK2 Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.
TK2 Antibody (C-term) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
This gene encodes a deoxyribonucleoside kinase that specifically phosphorylates thymidine, deoxycytidine, and deoxyuridine. The encoded enzyme localizes to the mitochondria and is required for mitochondrial DNA synthesis. Mutations in this gene are associated with a myopathic form of mitochondrial DNA depletion syndrome. Alternate splicing results in multiple transcript variants.
REFERENCES
Davila, S., et al. Genes Immun. 11(3):232-238(2010) Sato, N., et al. Am. J. Hum. Genet. 85(5):544-557(2009) Collins, J., et al. Neuromuscul. Disord. 19(11):784-787(2009) Villarroya, J., et al. Exp. Cell Res. 315(8):1429-1438(2009) Frangini, M., et al. FEBS J. 276(4):1104-1113(2009)